NDUFB9 and osteosarcoma: However, we are not aware of any study on the immunological aspects of FDX1, TOMM20, NDUFB9, COX11, MFN2 and ATP6V1E1 in osteosarcoma for the time being, which is a direction we need to study subsequently.